Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis

Araujo, DV; Wells, JC; Hansen, AR; Dizman, N; Pal, SK; Beuselinck, B; Donskov, F; Gan, CL; Yan, F; Tran, B; Kollmannsberger, CK; de Velasco, G; Yuasa, T; Reaume, MN; Ernst, DS; Powles, T; Bjarnason, GA; Choueiri, TK; Heng, DYC; Dudani, S

Dudani, S (corresponding author), William Osler Hlth Syst, Brampton Civ Hosp, Brampton, ON L6R 3J7, Canada.

JOURNAL OF GERIATRIC ONCOLOGY, 2021; 12 (5): 820

Abstract

Objective: Older adults with metastatic renal cell carcinoma(mRCC) are underrepresented in immune-checkpoint inhibitor(ICI) registration trials. Here ......

Full Text Link